Updated Guidelines for Controlled Trials of Acute Treatment of Migraine
New guidelines from the International Headache Society aim to affect the design, conduct, and reporting for clinical trials in migraine.
New guidelines from the International Headache Society aim to affect the design, conduct, and reporting for clinical trials in migraine.
Rapid eye movement sleep behavior disorder features may be a clinical marker for faster cognitive decline in Parkinson disease.
Lipid-lowering was associated with an increased risk for stroke in secondary prevention trials alone.
Women vs men with tension-type headache may have a higher number of trigger points and lower pressure pain thresholds.
For certain patients with complex pain patterns, stimulating both dorsal root ganglion and dorsal columns may relieve pain effectively.
Inhibition of trigeminal nociception may be impaired in individuals with migraine.
The American Heart Association has updated its scientific statement on blood pressure readings.
In order to revise the guidelines, the Task Force reviewed clinical trials presented at the annual scientific meetings of the ACC, AHA, HRS, and European Society of Cardiology in addition to other peer-reviewed, published data.
These results suggest that CHA2DS2-VASc scores should be continually reassessed, perhaps annually, in patients with atrial fibrillation.
Approximately half of patients with migraine have kinesiophobia, and the condition is associated with greater severity, not presence of cutaneous allodynia.